comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 17:21:20 - browse：3

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Mirador, a new biotech startup, launches with $400 million

hotspot

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Mass General, Mayo Clinic look to monetize custom

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Maisha Meds is a PBM, but don't call it that

TikTok, Instagram influencers need more rules for drug ads

Medicare bonuses could stop drug shortages under Senate plan

focus

comprehensive

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Sports medicine is finally prioritizing gender equality

Dog Aging Project founders on what lies ahead after losing funding

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cardiologists urge adding sexual orientation, gender identity to health records

Bright Health sells Medicare Advantage business to Molina

Dog Aging Project founders on what lies ahead after losing funding

How to save PrEP access — and even expand it

Head of FDA's diagnostics center, who led through Covid, retires

hotspot

FDA sets aggressive timeline for overhauling inspection procedures

This gene therapy has record $4.25 million price. It's saved children.

FDA sets aggressive timeline for overhauling inspection procedures

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Printout prescription drug information shouldn’t go digital

There's an unseen cost to disruptive road

knowledge

focus

hotspot

hotspot